95% CI 0.86, 0.93 at 7 years) for both liraglutide and semaglutide among GLP-1RAs.69 This study was included in another analysis including both randomised and some of the non-randomised data previously presented and reported a lower risk of all-cause dementia associated with any GLP-1RA.70 Two further network meta-analyses of selected publications71 72 ranked GLP-1RAs second for reducing the risk of dementia, including AD
Hematologic and Lymphatic System: Anemia, etc
Conclusions GLP-1R KO mice exhibit impaired brain glucose metabolism to high doses of exogenous glucose, and they also have reduced functional connectivity
Dehydration is very common Report any vomiting, light-headedness, upper abdominal pain, or upper or mid-back pain to your clinician Consult with your ophthalmologist and let them know you are on a GLP-1 agonist These are not all the risks or potential adverse effects If you liked this article, you may also enjoy reading The History of Insulin and Type 1 Diabetes
For international patients seeking trusted care, Turkey has emerged as a global hub for wellness and medical tourism thanks to its advanced healthcare infrastructure, certified clinics, and affordability